ACHV - ACHIEVE LIFE SCIENCES, INC.
2.65
-0.240 -9.057%
Share volume: 1,234,058
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$2.89
-0.24
-0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-07-2024 | 03-11-2025 | 05-13-2025 | 08-07-2025 | 11-06-2025 | 03-24-2026 | |
| Assets | |||||||||
| Total Assets | 70.029 M | 64.791 M | 47.917 M | 38.633 M | 27.358 M | 58.935 M | 52.040 M | 41.790 M | |
| Current Assets | 67.709 M | 62.519 M | 45.529 M | 36.467 M | 25.000 M | 56.903 M | 50.055 M | 39.889 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 46.557 M | 33.367 M | 21.607 M | 10.229 M | 3.523 M | 16.184 M | 15.475 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 66.398 M | 14.756 M | 9.544 M | 12.753 M | 13.016 M | 51.874 M | 31.930 M | 20.929 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.320 M | 2.272 M | 2.388 M | 2.166 M | 2.358 M | 2.032 M | 1.985 M | 1.901 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 70.029 M | 64.791 M | 47.917 M | 38.633 M | 27.358 M | 58.935 M | 52.040 M | 41.790 M | |
| Total liabilities | 20.573 M | 22.506 M | 16.539 M | 17.734 M | 17.079 M | 17.267 M | 18.425 M | 20.272 M | |
| Total current liabilities | 20.573 M | 13.702 M | 6.716 M | 6.682 M | 7.130 M | 8.573 M | 9.730 M | 9.082 M | |
| Accounts Payable | 373.000 K | 550.000 K | 1.011 M | 1.950 M | 1.656 M | 1.218 M | 1.943 M | 867.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 1.215 M | 1.292 M | 37.000 K | 21.000 K | 5.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 8.804 M | 9.823 M | 9.837 M | 8.657 M | 8.657 M | 8.674 M | 11.185 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 1.215 M | 1.292 M | 37.000 K | 21.000 K | 5.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 49.456 M | 42.285 M | 31.378 M | 20.899 M | 10.279 M | 41.668 M | 33.615 M | 21.518 M | |
| Common stock | 221.697 M | 222.998 M | 224.521 M | 226.446 M | 228.678 M | 272.788 M | 279.170 M | 281.734 M | |
| Retained earnings | -172.245 M | -180.706 M | -193.218 M | -205.578 M | -218.405 M | -231.123 M | -245.564 M | -260.226 M |